VRCA
Verrica Pharmaceuticals Inc
Halal Rating :
Last Price
$0.66
Last updated:
Market Cap
-
7D Change
4.33%
1 Year Change
-88.64%
Company Overview
Industries
Exchange
Next Earnings Date
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company focused on developing and commercializing innovative treatments for skin diseases. Their lead product candidate, VP-102, is a proprietary drug-device combination for the treatment of molluscum contagiosum, common warts, and external genital warts.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $-1781000.0 | $21.3m | - | $2.38m | 0.00% | 11.16% |
| June 30, 2024 | $5.18m | $22.75m | - | $2.37m | 0.00% | 10.41% |
| March 31, 2024 | $3.83m | $24.74m | - | $2.32m | 0.00% | 9.37% |
Company Impact
Help us evaluate Verrica Pharmaceuticals Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.